Fidelity Investments’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.8M | Buy |
661,997
+122,119
| +23% | +$10.8M | ﹤0.01% | 1314 |
|
|
2025
Q4 | $47.2M | Buy |
539,878
+19,214
| +4% | +$1.57M | ﹤0.01% | 1467 |
|
|
2025
Q3 | $34.6M | Sell |
520,664
-17,768
| -3% | -$1.01M | ﹤0.01% | 1584 |
|
|
2025
Q2 | $29.8M | Buy |
538,432
+60,089
| +13% | +$2.88M | ﹤0.01% | 1568 |
|
|
2025
Q1 | $23.1M | Buy |
478,343
+35,827
| +8% | +$1.5M | ﹤0.01% | 1630 |
|
|
2024
Q4 | $17.1M | Sell |
442,516
-11,680
| -3% | -$509K | ﹤0.01% | 1780 |
|
|
2024
Q3 | $20.4M | Buy |
454,196
+19,737
| +5% | +$797K | ﹤0.01% | 1698 |
|
|
2024
Q2 | $15.1M | Sell |
434,459
-31,626
| -7% | -$926K | ﹤0.01% | 1747 |
|
|
2024
Q1 | $13.5M | Buy |
466,085
+133
| +0% | +$3.62K | ﹤0.01% | 1786 |
|
|
2023
Q4 | $10.7M | Sell |
465,952
-43,290
| -9% | -$757K | ﹤0.01% | 1832 |
|
|
2023
Q3 | $8.49M | Buy |
509,242
+1,835
| +0.4% | +$35.6K | ﹤0.01% | 1868 |
|
|
2023
Q2 | $14M | Buy |
507,407
+459,087
| +950% | +$11.5M | ﹤0.01% | 1763 |
|
|
2023
Q1 | $1.11M | Sell |
48,320
-20,206
| -29% | -$339K | ﹤0.01% | 2503 |
|
|
2022
Q4 | $748K | Sell |
68,526
-2,740,282
| -98% | -$23.1M | ﹤0.01% | 2612 |
|
|
2022
Q3 | $23.7M | Sell |
2,808,808
-682,198
| -20% | -$6.46M | ﹤0.01% | 1559 |
|
|
2022
Q2 | $27.6M | Sell |
3,491,006
-3,637,573
| -51% | -$44M | ﹤0.01% | 1525 |
|
|
2022
Q1 | $169M | Buy |
7,128,579
+281,302
| +4% | +$7.93M | 0.01% | 854 |
|
|
2021
Q4 | $234M | Buy |
6,847,277
+354,639
| +5% | +$11.2M | 0.02% | 743 |
|
|
2021
Q3 | $115M | Sell |
6,492,638
-623,745
| -9% | -$26.6M | 0.01% | 1040 |
|
|
2021
Q2 | $319M | Buy |
7,116,383
+545,156
| +8% | +$18M | 0.03% | 629 |
|
|
2021
Q1 | $170M | Buy |
6,571,227
+118,463
| +2% | +$3M | 0.01% | 860 |
|
|
2020
Q4 | $130M | Buy |
6,452,764
+1,251,683
| +24% | +$26.9M | 0.01% | 927 |
|
|
2020
Q3 | $102M | Buy |
5,201,081
+35,876
| +0.7% | +$673K | 0.01% | 895 |
|
|
2020
Q2 | $91.2M | Buy |
5,165,205
+1,071,061
| +26% | +$13.4M | 0.01% | 907 |
|
|
2020
Q1 | $28.9M | Buy |
4,094,144
+13,177
| +0.3% | +$98.7K | ﹤0.01% | 1255 |
|
|
2019
Q4 | $28.8M | Buy |
4,080,967
+138,955
| +4% | +$1.38M | ﹤0.01% | 1456 |
|
|
2019
Q3 | $47.3M | Buy |
3,942,012
+432,608
| +12% | +$5.45M | 0.01% | 1184 |
|
|
2019
Q2 | $42.5M | Sell |
3,509,404
-97,845
| -3% | -$1.08M | 0.01% | 1307 |
|
|
2019
Q1 | $45.3M | Sell |
3,607,249
-20,653
| -0.6% | -$182K | 0.01% | 1258 |
|
|
2018
Q4 | $24.4M | Buy |
3,627,902
+170,500
| +5% | +$1.35M | ﹤0.01% | 1483 |
|
|
2018
Q3 | $35.6M | Buy |
3,457,402
+276,819
| +9% | +$2.38M | ﹤0.01% | 1436 |
|
|
2018
Q2 | $21.4M | Buy |
3,180,583
+15,017
| +0.5% | +$115K | ﹤0.01% | 1695 |
|
|
2018
Q1 | $27.2M | Buy |
3,165,566
+93,617
| +3% | +$1.76M | ﹤0.01% | 1581 |
|
|
2017
Q4 | $63.9M | Buy |
3,071,949
+536,535
| +21% | +$9.52M | 0.01% | 1183 |
|
|
2017
Q3 | $44.8M | Buy |
2,535,414
+6,952
| +0.3% | +$96.3K | 0.01% | 1353 |
|
|
2017
Q2 | $28.6M | Buy |
2,528,462
+10,264
| +0.4% | +$110K | ﹤0.01% | 1529 |
|
|
2017
Q1 | $32.3M | Buy |
2,518,198
+11,031
| +0.4% | +$178K | ﹤0.01% | 1500 |
|
|
2016
Q4 | $55.1M | Buy |
2,507,167
+378,448
| +18% | +$8.44M | 0.01% | 1255 |
|
|
2016
Q3 | $45M | Buy |
+2,128,719
| New | +$29.1M | 0.01% | 1345 |
|
Other funds holding PTGX
FCM
RI
VPM
VCM
JJ